Neurobiological Tech (NTII) | Stock Discussion Forums

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical
Neurobiological Tech (NTII)

An SI Board Since September 1996

Posts	SubjectMarks	Bans	Symbol
1494	40	0	NTII

Emcee: Miles Rhyne Hoffman, CFA	Type: Unmoderated

Introduction Market Data Compact

Go to reply# or date (mm/dd/yy):

Reply	Message Preview	From	Recs	Posted
1469	<i>I don't know if anyone else noticed but Celtic Pharma put out a PR	DewDiligence_on_SI	-	12/5/2007
1468	Celtic Pharma Reports Data Presented at Society for Neuro-Oncology Annual Meetin	sim1	-	12/5/2007
1467	I think it will be tough for the buyers to get out. Too thinly traded and they h	rkrw	-	12/4/2007
1466	<i>This is my only point...and its just speculation on my part</i>	Steve Lokness	-	12/4/2007
1465	First, they virtually bought the company for the cash paid for the new shares.	keokalani'nui	-	12/4/2007
1464	Welllll, maybe "commercial" success was the wrong choice of words. But	Steve Lokness	-	12/4/2007
1463	Am I missing something? How could V be a commercial success in 8 months?	keokalani'nui	-	12/4/2007
1462	If clinical trials for the Buck compound are going to take a while, then the add	JMarcus	-	12/4/2007
1461	<i>I bet recent investors hang around no longer than 8 months.</i>	Steve Lokness	-	12/4/2007
1460	ntii guided in last call they were looking to in-license a cpd (I paraphrase) &#	keokalani'nui	-	12/4/2007
1459	Seems out of left field to me. It's possible the new buyers knew about it un	rkrw	-	12/3/2007
1458	Jim, does this news strike you as coming out of left field? Leastwise the marke	JMarcus	-	12/3/2007
1457	Tables: New Coverage Upgrades & Downgrades Neurobiological Technologies - NT	mopgcw	-	12/3/2007
1456	Neurobiological Technologies Announces Pricing of Its $60 Million Common Stock O	sim1	-	10/31/2007
1455	I follow them more out of curiosity. One problem is any stroke program which suc	rkrw	-	10/6/2007
1454	rkrw, Didn't realize you follow NTII(D). I've looked at it and didn	ghmm	-	10/6/2007
1453	NTII putting out more info. sec.gov	rkrw	-	10/6/2007
1452	The 1 for 7 reverse stock split becomes effective on Sept. 17th. There will be	JMarcus	-	9/14/2007
1451	When I referred to the lack of optimism, I am referring to the perception--which	NeuroInvestment	-	8/24/2007
1450	Thanks on pars. I wonder which group does better, post reverse split, or post fa	rkrw	-	8/24/2007
1449	<i>, but there aren't many (any) I can find who are optimistic about V	Steve Lokness	-	8/24/2007
1448	Pharmos (PARS) did a reverse split in 2005, 1/5. Also not a ringing endorsement	NeuroInvestment	-	8/24/2007
1447	Interesting list - thanks for posting. Not very successful company NTII is join	Steve Lokness	-	8/23/2007
1446	Out of curiosity I went over my biocaps list and found these splits: * Genta:	rkrw	-	8/23/2007
1445	Peter; Healthy companies don't have to do reverse splits. What drove NTII d	Steve Lokness	-	8/23/2007

Go to reply# or date (mm/dd/yy):